Microarrays reveal distinct gene signatures in the thymus of seropositive and seronegative myasthenia gravis patients and the role of CC chemokine ligand 21 in thymic hyperplasia

Journal of Immunology

Volumn 177, Issue 11, 2006, Pages 7868-7879

  Le Panse, Rozen ^a   Cizeron Clairac, Géraldine ^a   Bismuth, Jacky ^a   Berrih Aknin, Sonia ^a  

^a CENTRE CHIRURGICAL MARIE LANNELONGUE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLINESTERASE INHIBITOR; COMPLEMENTARY DNA; HLA DR ANTIGEN; IMMUNOGLOBULIN; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; RNA; SECONDARY LYMPHOID TISSUE CHEMOKINE;

ADULT; ARTICLE; AUTOIMMUNE DISEASE; CHEMOTAXIS; FEMALE; GENE EXPRESSION; HUMAN; HUMAN TISSUE; INFANT; MICROARRAY ANALYSIS; MYASTHENIA GRAVIS; NEUROLOGIC DISEASE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; REAL TIME POLYMERASE CHAIN REACTION; THYMECTOMY; THYMUS; UNINDEXED SEQUENCE;

EID: 33751558801     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.177.11.7868     Document Type: Article

References (55)

1. Aharonov, A., O. Abramsky, R. Tarrab-Hazdai, and S. Fuchs. 1975. Humoral antibodies to acetylcholine receptor in patients with myasthenia gravis. Lancet 2: 340-342.
2. Evoli, A., A. P. Batocchi, M. Lo Monaco, S. Servidei, L. Padua, L. Majolini, and P. Tonali. 1996. Clinical heterogeneity of seronegative myasthenia gravis. Neuromuscul. Disord. 6: 155-161.
3. Hoch, W., J. McConville, S. Helms, J. Newsom-Davis, A. Melms, and A. Vincent. 2001. Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies. Nat. Med. 7: 365-368.
4. Berrih-Aknin, S., and B. Eymard. 1999. Thymus et pathologies. Biologie 5: 579-585.
5. Derbinski, J., J. Gabler, B. Brors, S. Tierling, S. Jonnakuty, M. Hergenhahn, L. Peltonen, J. Walter, and B. Kyewski. 2005. Promiscuous gene expression in thymic epithelial cells is regulated at multiple levels. J. Exp. Med. 202: 33-45.
6. Berrih-Aknin, S., E. Morel, F. Raimond, D. Safar, C. Gaud, J. Binet, P. Levasseur, and J. Bach. 1987. The role of the thymus in myasthenia gravis: immunohistological and immunological studies in 115 cases. Ann. N.Y. Acad. Sci. 505: 50-70.
7. Kuks, J. B., H. J. Oosterhuis, P. C. Limburg, and T. H. The. 1991. Anti-acetylcholine receptor antibodies decrease after thymectomy in patients with myasthenia gravis: clinical correlations. J. Autoimmun. 4: 197-211.
8. Wakkach, A., T. Guyon, C. Bruand, S. Tzartos, S. Cohen-Kaminsky, and S. Berrih-Aknin. 1996. Expression of acetylcholine receptor genes in human thymic epithelial cells: implications for myasthenia gravis. J. Immunol. 157: 3752-3760.
9. Safar, D., S. Berrih-Aknin, and E. Morel. 1987. In vitro anti-acetylcholine receptor antibody synthesis by myasthenia gravis patient lymphocytes: correlations with thymic histology and thymic epithelial-cell interactions. J Clin. Immunol. 7: 225-234.
10. Melms, A., B. C. Schalke, T. Kirchner, H. K. Muller-Hermelink, E. Albert, and H. Wekerle. 1988. Thymus in myasthenia gravis: isolation of T-lymphocyte lines specific for the nicotinic acetylcholine receptor from thymuses of myasthenic patients. J. Clin. Invest. 81: 902-908.
11. Evoli, A., P. A. Tonali, L. Padua, M. L. Monaco, F. Scuderi, A. P. Batocchi, M. Marino, and E. Bartoccioni. 2003. Clinical correlates with anti-MuSK antibodies in generalized seronegative myasthenia gravis. Brain 126: 2304-2311.
12. Leite, M. I., P. Strobel, M. Jones, K. Micklem, R. Moritz, R. Gold, E. H. Niks, S. Berrih-Aknin, F. Scaravilli, A. Canelhas, et al. 2005. Fewer thymic changes in MuSK antibody-positive than in MuSK antibody-negative MG. Ann. Neurol. 57: 444-448.
13. Lauriola, L., F. Ranelletti, N. Maggiano, M. Guerriero, C. Punzi, F. Marsili, E. Bartoccioni, and A. Evoli. 2005. Thymus changes in anti-MuSK-positive and -negative myasthenia gravis. Neurology 64: 536-538.
14. Moulian, N., J. Bidault, F. Truffault, A. M. Yamamoto, P. Levasseur, and S. Berrih-Aknin. 1997. Thymocyte Fas expression is dysregulated in myasthenia gravis patients with anti-acetylcholine receptor antibody. Blood 89: 3287-3295.
15. Price, P., C. Witt, R. Allcock, D. Sayer, M. Garlepp, C. C. Kok, M. French, S. Mallal, and F. Christiansen. 1999. The genetic basis for the association of the 8.1 ancestral haplotype (A1, B8, DR3) with multiple immunopathological diseases. Immunol. Rev. 167: 257-274.
16. Poëa-Guyon, S., P. Christadoss, R. Le Panse, T. Guyon, M. De Baets, A. Wakkach, J. Bidault, S. Tzartos, and S. Berrih-Aknin. 2005. Effects of cytokines on acetylcholine receptor expression: implications for myasthenia gravis. J. Immunol. 174: 5941-5949.
17. Shiina, T., A. Ando, Y. Suto, F. Kasai, A. Shigenari, N. Takishima, E. Kikkawa, K. Iwata, Y. Kuwano, Y. Kitamura, et al. 2001. Genomic anatomy of a premier major histocompatibility complex paralogous region on chromosome 1q21-q22. Genome Res. 11: 789-802.
18. Kasahara, M., J. Nakaya, Y. Satta, and N. Takahata. 1997. Chromosomal duplication and the emergence of the adaptive immune system. Trends Genet. 13: 90-92.
19. Goluszko, E., C. Deng, M. A. Poussin, and P. Christadoss. 2002. Tumor necrosis factor receptor p55 and p75 deficiency protects mice from developing experimental autoimmune myasthenia gravis. J. Neuroimmunol. 122: 85-93.
20. Deng, C., E. Goluszko, E. Tuzun, H. Yang, and P. Christadoss. 2002. Resistance to experimental autoimmune myasthenia gravis in IL-6-deficient mice is associated with reduced germinal center formation and C3 production. J. Immunol. 169: 1077-1083.
21. Goidl, E. A., and G. W. Siskind. 1974. Ontogeny of B-lymphocyte function. I. Restricted heterogeneity of the antibody response of B lymphocytes from neonatal and fetal mice. J. Exp. Med. 140: 1285-1302.
22. Cyster, J. G. 2005. Chemokines, sphingosine-1-phosphate, and cell migration in secondary lymphoid organs. Annu. Rev. Immunol. 23: 127-159.
23. Feferman, T., P. K. Maiti, S. Berrih-Aknin, J. Bismuth, J. Bidault, S. Fuchs, and M. C. Souroujon. 2005. Overexpression of IFN-induced protein 10 and its receptor CXCR3 in myasthenia gravis. J. Immunol. 174: 5324-5331.
24. Bleul, C. C., and T. Boehm. 2000. Chemokines define distinct microenvironments in the developing thymus. Eur. J. Immunol. 30: 3371-3379.
25. Mesnard-Rouiller, L., J. Bismuth, A. Wakkach, S. Poea-Guyon, and S. Berrih-Aknin. 2004. Thymic myoid cells express high levels of muscle genes. J. Neuroimmunol. 148: 97-105.
26. Hjelmervik, T. O., K. Petersen, I. Jonassen, R. Jonsson, and A. I. Bolstad. 2005. Gene expression profiling of minor salivary glands clearly distinguishes primary Sjogren's syndrome patients from healthy control subjects. Arthritis Rheum. 52: 1534-1544.
27. Ishii, T., H. Onda, A. Tanigawa, S. Ohshima, H. Fujiwara, T. Mima, Y. Katada, H. Deguchi, M. Suemura, T. Miyake, et al. 2005. Isolation and expression profiling of genes upregulated in the peripheral blood cells of systemic lupus erythematosus patients. DNA Res. 12: 429-439.
28. Legler, D. F., M. Loetscher, R. S. Roos, I. Clark-Lewis, M. Baggiolini, and B. Moser. 1998. B cell-attracting chemokine 1, a human CXC chemokine expressed in lymphoid tissues, selectively attracts B lymphocytes via BLR1/ CXCR5. J. Exp. Med. 187: 655-660.
29. Luther, S. A., T. Lopez, W. Bai, D. Hanahan, and J. G. Cyster. 2000. BLC expression in pancreatic islets causes B cell recruitment and lymphotoxin-dependent lymphoid neogenesis. Immunity 12: 471-481.
30. McLachlan, S. M., L. V. Nicholson, G. Venables, F. L. Mastalgia, D. Bates, B. R. Smith, and R. Hall. 1981. Acetylcholine receptor antibody synthesis in lymphocyte cultures. J. Clin. Lab. Immunol 5: 137-142.
31. Sims, G. P., H. Shiono, N. Willcox, and D. I. Stott. 2001. Somatic hypermutation and selection of B cells in thymic germinal centers responding to acetylcholine receptor in myasthenia gravis. J. Immunol. 167: 1935-1944.
32. k families. Clin. Exp. Immunol. 83: 262-266.
33. Chang, C. H., S. Guerder, S. C. Hong, W. van Ewijk, and R. A. Flavell. 1996. Mice lacking the MHC class II transactivator (CIITA) show tissue-specific impairment of MHC class II expression. Immunity 4: 167-178.
34. Hughes, A. L., and M. Nei. 1993. Evolutionary relationships of the classes of major histocompatibility complex genes. Immunogenetics 37: 337-346.
35. Nagane, Y., K. Utsugisawa, D. Obara, M. Yamagata, and H. Tohgi. 2003. Dendritic cells in hyperplastic thymuses from patients with myasthenia gravis. Muscle Nerve 27: 582-589.
36. Gunn, M. D., S. Kyuwa, C. Tam, T. Kakiuchi, A. Matsuzawa, L. T. Williams, and H. Nakano. 1999. Mice lacking expression of secondary lymphoid organ chemokine have defects in lymphocyte homing and dendritic cell localization. J. Exp. Med. 189: 451-460.
37. Martin, A. P., E. C. Coronel, G. Sano, S. C. Chen, G. Vassileva, C. Canasto-Chibuque, J. D. Sedgwick, P. S. Frenette, M. Lipp, G. C. Furtado, and S. A. Lira. 2004. A novel model for lymphocytic infiltration of the thyroid gland generated by transgenic expression of the CC chemokine CCL21. J. Immunol. 173: 4791-4798.
38. Badr, G., G. Borhis, D. Treton, and Y. Richard. 2005. IFN α enhances human B-cell chemotaxis by modulating ligand-induced chemokine receptor signaling and internalization. Int. Immunol. 17: 459-467.
39. Sharma, S., S. C. Yang, S. Hillinger, L. X. Zhu, M. Huang, R. K. Batra, J. F. Lin, M. D. Burdick, R. M. Strieter, and S. M. Dubinett. 2003. SLC/CCL21-mediated anti-tumor responses require IFNγ, MIG/CXCL9 and IP-10/CXCL10. Mol. Cancer 2: 22.
40. Barone, F., M. Bombardieri, A. Manzo, M. C. Blades, P. R. Morgan, S. J. Challacombe, G. Valesini, and C. Pitzalis. 2005. Association of CXCL13 and CCL21 expression with the progressive organization of lymphoid-like structures in Sjogren's syndrome. Arthritis Rheum. 52: 1773-1784.
41. Takemura, S., A. Braun, C. Crowson, P. J. Kurtin, R. H. Cofield, W. M. O'Fallon, J. J. Goronzy, and C. M. Weyand. 2001. Lymphoid neogenesis in rheumatoid synovitis. J. Immunol. 167: 1072-1080.
42. Meraouna, A., G. Cizeron-Clairac, R. L. Panse, J. Bismuth, F. Truffault, C. Talaksen, and S. Berrih-Aknin. 2006. The chemokine CXCL13 is a key molecule in autoimmune myasthenia gravis. Blood 108: 432-440.
43. Storto, M., U. de Grazia, G. Battaglia, M. P. Felli, M. Maroder, A. Gulino, G. Ragona, F. Nicoletti, I. Screpanti, L. Frati, and A. Calogero. 2000. Expression of metabotropic glutamate receptors in murine thymocytes and thymic stromal cells. J. Neuroimmunol. 109: 112-120.
44. Vincent, A., O. Lily, and J. Palace. 1999. Pathogenic autoantibodies to neuronal proteins in neurological disorders. J. Neuroimmunol. 100: 169-180.
45. Green, A. R., A. H. Hainsworth, A. Misra, T. A. Debens, D. M. Jackson, T. K. Murray, R. M. Nelson, and A. J. Cross. 2001. The interaction of AR-A008055 and its enantiomers with the GABA(A) receptor complex and their sedative, muscle relaxant and anticonvulsant activity. Neuropharmacology 41: 167-174.
46. van der Geld, H., and H. J. Oosterhuis. 1963. Muscle and thymus antibodies in myasthenia gravis. Vox Sang 8: 196-204.
47. Takaya, M., S. Kawahara, T. Namba, and D. Grob. 1992. Antibodies against myofibrillar proteins in myasthenia gravis patients. Tokai J. Exp. Clin. Med. 17: 35-39.
48. Mohan, S., R. J. Barohn, C. E. Jackson, and K. A. Krolick. 1994. Evaluation of myosin-reactive antibodies from a panel of myasthenia gravis patients. Clin. Immunol. Immunopathol. 70: 266-273.
49. Labrada, L., X. H. Liang, W. Zheng, C. Johnston, and B. Levine. 2002. Age-dependent resistance to lethal alphavirus encephalitis in mice: analysis of gene expression in the central nervous system and identification of a novel interferon-inducible protective gene, mouse ISG12. J. Virol. 76: 11688-11703.
50. Sjolin, H., E. Tomasello, M. Mousavi-Jazi, A. Bartolazzi, K. Karre, E. Vivier, and C. Cerboni. 2002. Pivotal role of KARAP/DAP12 adaptor molecule in the natural killer cell-mediated resistance to murine cytomegalovirus infection. J. Exp. Med. 195: 825-834.
51. Bakker, A. B., R. M. Hoek, A. Cerwenka, B. Blom, L. Lucian, T. McNeil, R. Murray, L. H. Phillips, J. D. Sedgwick, and L. L. Lanier. 2000. DAP12-deficient mice fail to develop autoimmunity due to impaired antigen priming. Immunity 13: 345-353.
52. Sun, C. T., W. Y. Lo, I. H. Wang, Y. H. Lo, S. R. Shiou, C. K. Lai, and L. P. Ting. 2001. Transcription repression of human hepatitis B virus genes by negative regulatory element-binding protein/SON. J. Biol. Chem. 276: 24059-24067.
53. Bach, J. F. 2005. Infections and autoimmune diseases. J. Autoimmun. 25(Suppl.): 74-80.
54. Schwimmbeck, P. L., T. Dyrberg, D. B. Drachman, and M. B. Oldstone. 1989. Molecular mimicry and myasthenia gravis: an autoantigenic site of the acetylcholine receptor u-subunit that has biologic activity and reacts immunochemically with herpes simplex virus. J. Clin. Invest. 84: 1174-1180.
55. Yager, T. D., A. A. Dempsey, H. Tang, D. Stamatiou, S. Chao, K. W. Marshall, and C. C. Liew. 2004. First comprehensive mapping of cartilage transcripts to the human genome. Genomics 84: 524-535.